News

Deal Announcements

Agile Therapeutics Adds Venture Capital Round

Thursday, August 2, 2012 5:35:00 AM PDT | VentureDeal
Princeton, New Jersey  --  Pharmaceutical company Agile Therapeutics has received $23.7 million in new venture capital investment, according to an SEC regulatory filing.

Agile is developing contraceptive pharmaceutical products that utilize its proprietary transdermal drug delivery technology.

Investors in the round were not disclosed, nor was how the company intends to use the funding proceeds.

Agile is still seeking $17 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1